Guillaume Bado

2.0k total citations
22 papers, 216 citations indexed

About

Guillaume Bado is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Guillaume Bado has authored 22 papers receiving a total of 216 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 10 papers in Virology and 7 papers in Epidemiology. Recurrent topics in Guillaume Bado's work include HIV/AIDS Research and Interventions (13 papers), HIV/AIDS drug development and treatment (11 papers) and HIV Research and Treatment (10 papers). Guillaume Bado is often cited by papers focused on HIV/AIDS Research and Interventions (13 papers), HIV/AIDS drug development and treatment (11 papers) and HIV Research and Treatment (10 papers). Guillaume Bado collaborates with scholars based in Burkina Faso, France and Ivory Coast. Guillaume Bado's co-authors include Nongodo Firmin Kaboré, Adrien Sawadogo, Lassana Sangaré, Patrick Coffié, François Dabis, Christian Laurent, Pauline Penot, Hermann Somlaré, Joseph Drabo and Hans‐Georg Kräusslich and has published in prestigious journals such as PLoS ONE, JAIDS Journal of Acquired Immune Deficiency Syndromes and Journal of Medical Virology.

In The Last Decade

Guillaume Bado

21 papers receiving 213 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guillaume Bado Burkina Faso	8	159	130	90	52	13	22	216
Olivier Ségéral France	10	180 1.1×	118 0.9×	91 1.0×	48 0.9×	19 1.5×	28	242
Simnikiwe H. Mayaphi South Africa	9	93 0.6×	52 0.4×	148 1.6×	95 1.8×	12 0.9×	17	204
Sumet Ongwandee Thailand	6	164 1.0×	58 0.4×	136 1.5×	31 0.6×	29 2.2×	10	208
Julia Fleming United States	6	114 0.7×	65 0.5×	111 1.2×	87 1.7×	8 0.6×	16	224
Thomas Huleux France	10	116 0.7×	50 0.4×	101 1.1×	95 1.8×	8 0.6×	18	193
Y Saïdi France	6	99 0.6×	41 0.3×	116 1.3×	66 1.3×	5 0.4×	9	188
Philippe Chiliade United States	4	243 1.5×	127 1.0×	119 1.3×	20 0.4×	4 0.3×	5	261
Nália Ismael Mozambique	8	147 0.9×	63 0.5×	101 1.1×	26 0.5×	43 3.3×	20	183
Claudia Palladino Spain	10	172 1.1×	119 0.9×	66 0.7×	29 0.6×	21 1.6×	27	233
Daniela Bezemer Netherlands	6	196 1.2×	114 0.9×	134 1.5×	12 0.2×	22 1.7×	7	229

Countries citing papers authored by Guillaume Bado

Since Specialization

Citations

This map shows the geographic impact of Guillaume Bado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillaume Bado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillaume Bado more than expected).

Fields of papers citing papers by Guillaume Bado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillaume Bado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillaume Bado. The network helps show where Guillaume Bado may publish in the future.

Co-authorship network of co-authors of Guillaume Bado

This figure shows the co-authorship network connecting the top 25 collaborators of Guillaume Bado. A scholar is included among the top collaborators of Guillaume Bado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guillaume Bado. Guillaume Bado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poda, Armel, Nongodo Firmin Kaboré, Jacques Zoungrana, et al.. (2021). Sur-risque de diabète sucré et d’hypertension artérielle chez les personnes infectées par le VIH suivies à l’hôpital de jour du CHU Souro Sanou, Bobo-Dioulasso, Burkina Faso, 2018. Revue d Épidémiologie et de Santé Publique. 69(2). 72–77. 3 indexed citations

Villabona‐Arenas, Christian Julián, Sabrina Eymard‐Duvernay, Avelin F. Aghokeng, et al.. (2018). Short Communication: Nucleoside Reverse Transcriptase Inhibitors with Reduced Predicted Activity Do Not Impair Second-Line Therapy with Lopinavir/Ritonavir or Darunavir/Ritonavir. AIDS Research and Human Retroviruses. 34(6). 477–480. 4 indexed citations

Penot, Pauline, Guillaume Bado, Nongodo Firmin Kaboré, et al.. (2018). Secret intake of antiretroviral treatment and HIV-1 viremia in a public routine clinic in Burkina Faso: a surprising relationship. AIDS Care. 30(12). 1502–1506. 1 indexed citations

Kaboré, Nongodo Firmin, Sabrina Eymard‐Duvernay, Jacques Zoungrana, et al.. (2017). TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study. PLoS ONE. 12(11). e0186686–e0186686. 1 indexed citations

Ciaffi, Laura, Sabrina Eymard‐Duvernay, Suzanne Izard, et al.. (2017). Efficacy of dual therapy with protease inhibitors plus lamivudine as maintenance treatment in HIV-positive patients on second line in Africa : the ANRS 12286/MOBIDIP trial 96-week results. Journal of the International AIDS Society. 20. 29–29. 1 indexed citations

Coffié, Patrick, Boris Tchounga, Guillaume Bado, et al.. (2017). Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa. BMC Infectious Diseases. 17(1). 466–466. 19 indexed citations

Coffié, Patrick, Matthias Egger, Michael J. Vinikoor, et al.. (2017). Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa. BMC Infectious Diseases. 17(S1). 706–706. 21 indexed citations

Coffié, Patrick, Akouda Patassi, Guillaume Bado, et al.. (2017). Changes in viral hepatitis B screening practices over time in West African HIV clinics. Médecine et Maladies Infectieuses. 47(6). 394–400. 3 indexed citations

Ciaffi, Laura, Sinata Koulla‐Shiro, Ndèye Fatou Ngom Gueye, et al.. (2016). Dual therapy with a boosted protease inhibitor plus lamivudine is an effective maintenance strategy in patients on second-line antiretroviral therapy in Africa : the ANRS 12286/MOBIDIP trial. Journal of the International AIDS Society. 19. 2 indexed citations

10.

Guichet, Emilande, Avelin F. Aghokeng, Laetitia Serrano, et al.. (2016). Short Communication: High Viral Load and Multidrug Resistance Due to Late Switch to Second-Line Regimens Could Be a Major Obstacle to Reach the 90-90-90 UNAIDS Objectives in Sub-Saharan Africa. AIDS Research and Human Retroviruses. 32(12). 1159–1162. 25 indexed citations

11.

Poda, Armel, Nongodo Firmin Kaboré, Jacques Zoungrana, et al.. (2016). Pregnancy rate and birth outcomes among women receiving antiretroviral therapy in Burkina Faso: a retrospective cohort study. Pan African Medical Journal. 23. 105–105. 5 indexed citations

12.

Zoungrana, Jacques, et al.. (2016). Dissociation immuno-virologique chez les patients infectés par le VIH-1 sous traitement antirétroviral à l’Hôpital de jour de Bobo-Dioulasso de 2008 à 2012 (Burkina Faso). 3(1). 17–23.

13.

Zoungrana, Jacques, et al.. (2015). [Immuno-virologic dissociation in patients infected by HIV-1 under antiretroviral treatment at the Day hospital of Bobo-Dioulasso from 2008 to 2012 (Burkina Faso)].. PubMed. 30(4). 58–64. 1 indexed citations

14.

Tchounga, Boris, André Inwoley, Patrick Coffié, et al.. (2014). Re‐testing and misclassification of HIV‐2 and HIV‐1&2 dually reactive patients among the HIV‐2 cohort of The West African Database to evaluate AIDS collaboration. Journal of the International AIDS Society. 17(1). 19064–19064. 19 indexed citations

15.

Penot, Pauline, Guillaume Bado, Nongodo Firmin Kaboré, et al.. (2014). The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso. Journal of the International AIDS Society. 17(1). 18646–18646. 39 indexed citations

16.

Zoungrana, Jacques, et al.. (2013). Efficacité et tolérance d’une trithérapie antirétrovirale à base de ténofovir disoproxil-emtricitabine-éfavirenz chez les patients naïfs infectés par le VIH-1 à Bobo Dioulasso (Burkina Faso, 2009–2011). Bulletin de la Société de pathologie exotique. 106(4). 239–243. 2 indexed citations

17.

Bado, Guillaume, Pauline Penot, Corinne Amiel, et al.. (2013). Hepatitis B seroprevalence in HIV-infected patients consulting in a public day care unit in Bobo Dioulasso, Burkina Faso. Médecine et Maladies Infectieuses. 43(5). 202–207. 12 indexed citations

18.

Poda, Armel, Jacques Zoungrana, Nongodo Firmin Kaboré, et al.. (2013). Mortality of HIV-Infected Patients on Antiretroviral Therapy in a Large Public Cohort in West Africa, Burkina Faso: Frequency and Associated Factors. Advances in Infectious Diseases. 3(4). 281–289. 4 indexed citations

19.

Tebit, Denis M., Lassana Sangaré, Hermann Somlaré, et al.. (2009). Analysis of the diversity of the HIV‐1 pol gene and drug resistance associated changes among drug‐naïve patients in Burkina Faso. Journal of Medical Virology. 81(10). 1691–1701. 25 indexed citations

20.

Tebit, Denis M., Lassana Sangaré, Hermann Somlaré, et al.. (2008). HIV Drug Resistance Pattern Among HAART-Exposed Patients With Suboptimal Virological Response in Ouagadougou, Burkina Faso. JAIDS Journal of Acquired Immune Deficiency Syndromes. 49(1). 17–25. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact